Dual Sourcing To Help Mitigate Risk In The Supply Chain

This interview with Alan Lahaise, VP, Bus. Dev., Development & Manufacturing Services, PCI Pharma Services, discusses supply chain issues for the pharmaceutical industry and "dual sourcing" as an approach to eliminate risk.

Alan started his career at Ciba-Geigy as a sales representative and progressed through a variety of business development leadership roles at Medeva PLC, Quintiles, Aptuit, Patheon and Thermo Fisher Scientific (Fisher Clinical Services). Alan joined PCI Pharma Services in July 2021 where he is VP Business Development for global Manufacturing and EMEA Clinical Services.

Alan brings over thirty years sales team leadership experience within the CRO/CDMO sectors in North America, EMEA and APAC regions. His responsibility for services has ranged across small molecule API, large molecule biological drug substance development and manufacture through to formulation development, clinical and commercial manufacture of drug product (oral solid dose, soft gel capsules and sterile products).